ads

The anti-smoking drug ‘Chantix’ is showing promising sign during trial according to a new study.

The anti-smoking drug ‘Chantix’ is showing promising sign during trial according to a new study.

According to a new study the anti-smoking drug Chantix (Varenicline) is showing promising results during the trial period. The researchers said that they had gathered data from 1000 participant through phone. The researchers have discovered that 44 of the smokers want to give up smoking by reducing the number of puffs they have per day.

In a statement Dr. Michael Siegel, a Professor of Community Health Sciences at Boston University School of Public Health said, The main contribution of this study is that it demonstrates that for patients who are not ready to quit right away, the use of Chantix could be helpful in getting them to cut down, and then, eventually, to making a quit attempt .

To complete the study the researchers gathered 1,510 smokers from ten countries around the world. The participants wanted to quit smoking in two or three months. The researchers had given them 1 mg of Varenicline or 2 placebos per day for 24 weeks. The study had lasted for a year.

The researchers have discovered that by the fourth week 47.1 percent of the participants who received Varenicline had reduced smoking. The participants who have received placebo reduced their smoking by 31.1 percent. After another four weeks the participant s with the Varenicline reduced their smoking by 75 percent as the participant s with placebo reduced it by 15.1 percent.

The researchers said, At weeks 21-24, continuous smoking abstinence rates for participants who received Varenicline stood at 37.8%, compared with 12.5% who received the placebo, while at weeks 21-52, abstinence rates were 27% for the Varenicline group and 9.9% for the placebo group. Among the side effects of Varenicline are constipation and weight gain .

Lead author of the study Dr. Jon Ebbert, Professor of Medicine at the Mayo Clinic in Rochester, Minn., said, Some smokers prefer to reduce the number of cigarettes that they smoke before quitting smoking completely . In another statement researchers said, Developing effective interventions to achieve tobacco abstinence through gradual reduction could engage more smokers in quitting .

The anti-smoking drug ‘Chantix’ is showing promising sign during trial according to a new study.

  Tags :